Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Mucosal surfaces serve as critical battlegrounds where the immune system must balance tolerance to commensal organisms with rapid defense against pathogens.
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy that block specific proteins from slowing the immune response. As a result, ...
By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.
The human small intestine absorbs nutrients while protecting us from potentially harmful microbes. One of the cell types that ...
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic modalities such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results